Skip to main content
 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Nov 12, 2025
Expenses
$80,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

Find it Early Act of 2025, S. 1410. Requires insurance coverage for all breast cancer screening needed for early detection. HR 2541, Nuclear Medicine Clarification Act. A bill related to medical event reporting.

Theranostics report language in the FY26 Labor, Health and Human Services, Education, and Related Agencies (L-HHS) funding legislation. This language would help ensure that existing federal research funds allocated through the NIHs National Cancer Institute (NCI) can be leveraged, as appropriate, to further advance the field of theranostics and benefit Americans facing cancer.

Medicare Physician Fee Schedule reform legislation, Medicare Patient Access and Practice Stabilization Act (H.R. 879)

 Bills named in this filing 3
  • S. 1410
    Find It Early Act
  • H.R. 2541
    Nuclear Medicine Clarification Act of 2025
  • H.R. 879
    Medicare Patient Access and Practice Stabilization Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem